[HTML][HTML] Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway

L Dong, H Jiang, Z Kang, M Guan - Clinica Chimica Acta, 2023 - Elsevier
Drugs targeting DNA repair have developed rapidly in cancer therapy, and numerous
inhibitors have already been utilized in preclinical and clinical stages. To optimize the …

Patient-derived organoids as a model for tumor research

J Wang, X Feng, Z Li, Y Chen, W Huang - Progress in Molecular Biology …, 2022 - Elsevier
Cancer represents a leading cause of death, despite the rapid progress of cancer research,
leading to urgent need for accurate preclinical model to further study of tumor mechanism …

Stromal localization of inactive CD8+ T cells in metastatic mismatch repair deficient colorectal cancer

E Küçükköse, MJD Baars, M Amini, SJ Schraa… - British Journal of …, 2024 - nature.com
Background The determinants of metastasis in mismatch repair deficiency with high levels of
microsatellite instability (MSI-H) in colorectal cancer (CRC) are poorly understood. Here, we …

[HTML][HTML] Lymphatic invasion of plakoglobin-dependent tumor cell clusters drives formation of polyclonal lung metastases in colon cancer

E Küçükköse, J Laoukili, AN Gorelick, S Degner… - Gastroenterology, 2023 - Elsevier
Background & Aims Patients with colon cancer with liver metastases may be cured with
surgery, but the presence of additional lung metastases often precludes curative treatment …

Exploring the impact of MMR status in locally advanced Rectal Carcinoma: Insights into prognosis and treatment outcomes

BL Emst - 2024 - studenttheses.uu.nl
Exploring the impact of MMR status in locally advanced Rectal Carcinoma: Insights into
prognosis and treatment outcomes Bobbie-Louise van Emst (6377009) MSc student Drug …